IRadimed Corp
NASDAQ:IRMD
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
40.05
57.1909
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one IRMD stock under the Base Case scenario is 41.66 USD. Compared to the current market price of 52.75 USD, IRadimed Corp is Overvalued by 21%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
IRadimed Corp
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for IRMD cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
IRadimed Corp
Balance Sheet Decomposition
IRadimed Corp
Current Assets | 74.3m |
Cash & Short-Term Investments | 51.7m |
Receivables | 10.4m |
Other Current Assets | 12.2m |
Non-Current Assets | 20m |
PP&E | 14.4m |
Intangibles | 2.9m |
Other Non-Current Assets | 2.6m |
Current Liabilities | 8.1m |
Accounts Payable | 1.4m |
Accrued Liabilities | 3.7m |
Other Current Liabilities | 2.9m |
Non-Current Liabilities | 2.8m |
Other Non-Current Liabilities | 2.8m |
Earnings Waterfall
IRadimed Corp
Revenue
|
71.3m
USD
|
Cost of Revenue
|
-16.3m
USD
|
Gross Profit
|
55m
USD
|
Operating Expenses
|
-33.7m
USD
|
Operating Income
|
21.3m
USD
|
Other Expenses
|
-2.7m
USD
|
Net Income
|
18.6m
USD
|
Free Cash Flow Analysis
IRadimed Corp
USD | |
Free Cash Flow | USD |
IRMD Profitability Score
Profitability Due Diligence
IRadimed Corp's profitability score is 78/100. The higher the profitability score, the more profitable the company is.
Score
IRadimed Corp's profitability score is 78/100. The higher the profitability score, the more profitable the company is.
IRMD Solvency Score
Solvency Due Diligence
IRadimed Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Score
IRadimed Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
IRMD Price Targets Summary
IRadimed Corp
According to Wall Street analysts, the average 1-year price target for IRMD is 61.2 USD with a low forecast of 60.6 USD and a high forecast of 63 USD.
Dividends
Current shareholder yield for IRMD is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
IRMD Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging (MRI) compatible medical devices. The company is headquartered in Winter Springs, Florida and currently employs 110 full-time employees. The company went IPO on 2014-07-16. Its MRidium 3860+ MRI Compatible IV infusion pump system provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The firm sells its products primarily to hospitals and acute care facilities, both in the United States and internationally.
Contact
IPO
Employees
Officers
The intrinsic value of one IRMD stock under the Base Case scenario is 41.66 USD.
Compared to the current market price of 52.75 USD, IRadimed Corp is Overvalued by 21%.